HRSA-23-070: Developmental-Behavioral Pediatrics Training Program
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2022.
Health Resources and Services Administration offered grants of up to $283,000 to the applicants described in the notice. It expected to make about 15 awards worth $4.3 million in total. Applications closed on January 19, 2023.
From the official notice on Grants.gov, last changed January 5, 2023. Checked November 7, 2026.
- Award ceiling$283,000
- Total funding$4.3 million
- Expected awards15
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | October 21, 2022 |
|---|---|
| Deadline | January 19, 2023 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Public or nonprofit agencies, including institutions of higher education, are eligible to apply. For the purposes of this NOFO, an institution of higher education is defined as any college or university accredited by a regionalized body or bodies approved for such purpose by the Secretary of Education, and any teaching hospital which has higher learning among its purposes and functions, and which has a formal affiliation with an accredited school of medicine and a full-time academic medical staff holding faculty status in such school of medicine. Tribes and tribal organizations are eligible.
Is this a realistic fit?
- Past Autism Collaboration, Accountability, Research, Education, and Support awards averaged $981,155; this notice allows up to $283,000 per award.
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity to apply for funding under the Developmental-Behavioral Pediatrics (DBP) Training Program. By expanding the DBP workforce, children with a wide range of developmental and behavioral concerns will have increased access to evaluation and services that address medical and psychosocial aspects of development. Through this award, programs will: • Prepare DBP fellows and other long-term trainees (LTTs) for leadership roles as teachers, investigators, and clinicians. • Build workforce capacity to evaluate for, diagnose or rule out developmental disabilities (DD), including autism, and other behavioral health concerns. • Prepare trainees to participate in clinical care and research training across the broad range of behavioral and developmental health concerns. • Provide pediatric practitioners, residents, and medical students with essential psychosocial knowledge and clinical expertise. • Provide technical assistance (TA) to strengthen systems of care for children who may have autism/DD and their families. TA recipients may include state Title V Maternal and Child Health Services Block Grant agencies and community agencies. Each recipient will accomplish this purpose through five overarching objectives: Objective 1: Recruit and train 10 LTTs, including 5 DBP fellows and 5 other LTTs, over the 5-year period of performance. Objective 2: Conduct one activity per year to address equity and improve access to DBP services. Objective 3: Provide training to a minimum of 200 short- and medium-term trainees per year. Objective 4: Train a minimum of 150 practicing providers through continuing education per year. Objective 5: Provide a minimum of 10 technical assistance (TA) activities per year to strengthen systems of care for children who may have autism/DD and their families.
Who has won Autism Collaboration, Accountability, Research, Education, and Support grants before
From fiscal 2021 to 2025, Autism Collaboration, Accountability, Research, Education, and Support (93.877) awarded $103 million across 105 grant awards, an average of $981,155 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| University of California, Los Angeles | California | 6 | $8.5 million |
| The Children's Hospital of Philadelphia | Pennsylvania | 4 | $3.5 million |
| University of Wisconsin System | Wisconsin | 3 | $3.4 million |
| University of California, Davis | California | 3 | $2.8 million |
| The Regents of the University of Colorado | Colorado | 2 | $2.2 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-23-070 still open?
No. It closed on January 19, 2023.
Who can apply for Developmental-Behavioral Pediatrics Training Program?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Developmental-Behavioral Pediatrics Training Program?
Closed January 19, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $283,000 each. About $4.3 million in total across about 15 awards.
Who has won Autism Collaboration, Accountability, Research, Education, and Support grants before?
The largest recipients over five fiscal years were University of California, Los Angeles, The Children's Hospital of Philadelphia, University of Wisconsin System. The program made 105 awards worth $103 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)